- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT03405181
Effects of the Additional Weight on the Reaching Behavior of Pre Term Infants With Low Birth Weight
21 febbraio 2019 aggiornato da: Prof. Rodrigo Luiz Carregaro, University of Brasilia
Effects of the Additional Weight on the Reaching Behavior of Preterm Infants With Low Birth Weight: Randomized Controlled Trial
The effects of additional weight on early motor skills of infants have been increasingly studied.
During the reaching behavior, the additional weight has been shown benefits in certain kinematic variables in full term and preterm infants.
There is a growing interest in the study of populations at risk for motor development, especially considering interventions based on functional activities with the purpose of improving the neuromotor control, functional capacity and muscle strength.
The aim of the present study is to investigate the effect of a functional training with additional weight in the reaching behavior of preterm infants with low birth weight and to compare the effects with a full term population.
A controlled and randomized trial will be carried out with full term infants of adequate birth weight and preterm infants with low birth weight at 6 months of chronological or corrected age.
The participants will be recruited by convenience from the charts of a Public Hospital.
Participants will be randomly allocated into four groups: 1) adequate weight placebo group (AWPG); 2) adequate weight intervention group (AWIG); 2) low weight placebo group (LWPG) and 4) low weight intervention group (LWIG). .
The assessor will be blinded (no knowledge of groups allocation).
All infants will undergo a training program of eight sessions (2x/week; 4 weeks).
The AWIG and LWIG will receive the training with an additional weight (characterized by a bracelet with a weight of 20% of the mass of the upper limbs)and the AWPG and LWPG will receive the same training, however, without the additional weight (only the bracelets)..
All infants will be assessed in three different moments: 1) Pre-intervention: baseline, before the start of the intervention program; 2) Post-intervention: evaluation performed after the end of the program; and 3) Follow-up: evaluation performed seven days after the post-intervention assessment.
The following kinematic dependent variables will be calculated: straightness index, mean velocity and motion units and electromyographic variables: pattern of activation and recruitment of muscle fibers - Biceps brachialis, Triceps brachialis, Deltoid and Pectoralis Major muscles; co-activation between biceps and triceps.
The Qualisys Track Manager (QTM) and a wireless surface electromyography with 8-channels will be used.
If normality assumptions are met, a mixed 2X2 ANOVA with repeated measures will be applied, in order to verify differences between the intervention programs, considering the dependent variables.
Otherwise, non-parametric procedures of the same nature will be adopted.
The significance will be set at 5% (P<0.05).
Panoramica dello studio
Stato
Completato
Intervento / Trattamento
Tipo di studio
Interventistico
Iscrizione (Effettivo)
66
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
DF
-
Brasília, DF, Brasile, 72220-275
- Campus UnB Ceilandia
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
Da 6 mesi a 7 mesi (Bambino)
Accetta volontari sani
Sì
Sessi ammissibili allo studio
Tutto
Descrizione
Inclusion Criteria:
- Adequate weight infants: healthy infants born with gestational age between 38-42 weeks and adequate birth weight (> 2500 grams);
- Low weight infants: healthy infants born with gestational age between 32-36 weeks and 6 days and with low birth weight (between 1500 and 2500 grams).
Exclusion Criteria:
- Anoxiated infants;
- Signs of neurological impairment (eg, hypoxic-ischemic encephalopathies grade I, II and III, intracranial hemorrhage and neonatal seizures);
- Congenital malformations (eg myelomeningocele and achondroplasias);
- Syndromes (e.g Down Syndrome);
- Sensorial alterations (visual and auditory);
- Cardiorespiratory difficulties;
- Orthopedic impairments (e.g, congenital clubfoot);
- Apgar below 8 and 10 in the first and fifth minutes, respectively.
- Infants who do not attend any of the evaluations, who do not complete at least 80% of the training or who cry uncontrollably, not allowing at least 10 reachings in the evaluations and training. Those that present intercurrences that may compromise normal neurosensorimotor development (for example, recurrent pneumonia, kidney and intestinal infection).
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Training with additional weight
The infants will be submitted to a reaching behavior training program of 4 weeks, two times per week (totaling 8 sessions).
During this training program, infants will use a bracelet with an additional weight characterized by 20% of the total mass of the upper limb placed on both wrists.
This training will be adopted for the adequate weight intervention group and low weight intervention group.
|
The infants will be positioned in a reclined position.
A bracelet with an additional weight (20% of the total mass of the upper limb) will be placed on both wrists.
The training will happen 2x/week, during 4 weeks (8 sessions).
An object will be used to stimulate the reaching behavior, which will be displayed by the examiner (positioned in front of the infant), and presented in the midline at shoulder height, considering the distance from the arm's length of the infant to the height of the wrist.
The physiotherapist will draw the attention of the infant to the object, moving it momentarily so that the infant perceives it and reaches it.
After reaching, the object will be carefully removed and resubmitted in order to elicit a new movement.
The interval between each presentation will be of approximately 5 seconds.
At least 10 movements will be stimulated.
If the infant does not achieve the 10 reaches within the maximum interval of 15 minutes, the session will be terminated.
|
|
Comparatore placebo: Training without additional weight
The infants will be submitted to a reaching behavior training program of 4 weeks, two times per week (totaling 8 sessions).
During this training program, infants will use a bracelet without additional weight, placed on both wrists.
This training will be adopted for the adequate weight placebo group and low weight placebo group.
|
The infants will be positioned in a reclined position.
A bracelet without the additional weight will be placed on both wrists.
The training will happen 2x/week, during 4 weeks (8 sessions).
An object will be used to stimulate the reaching behavior, which will be displayed by the examiner (positioned in front of the infant), and presented in the midline at shoulder height, considering the distance from the arm's length of the infant to the height of the wrist.
The physiotherapist will draw the attention of the infant to the object, moving it momentarily so that the infant perceives it and reaches the object.
After reaching, the object will be carefully removed (or picked up) and resubmitted in order to elicit a new movement.
The interval between each presentation of the object will be of approximately 5 seconds.
At least 10 movements will be stimulated.
If the infant does not achieve the 10 reaches within the maximum interval of 15 minutes, the session will be terminated.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Movement unit
Lasso di tempo: Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
the number of maximum velocities between two minimum velocities, for which the difference was greater than 1 cm/s
|
Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
|
Electromyographic activity
Lasso di tempo: Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
Magnitude of the muscle recruitment during the reaching behavior, measured in microvolts (root mean square - RMS)
|
Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Mean Velocity
Lasso di tempo: Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
the ratio between the distance traveled during the reaching behavior and the duration of the movement
|
Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
|
Straightness Index
Lasso di tempo: Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
ratio between the minimal distance that could have been traveled in this trajectory (distance between the initial position of the hand and the object) and the distance traveled by the hand (total trajectory).
The closer is this index to 1, the straighter is the trajectory.
|
Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
|
Grasping
Lasso di tempo: Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
categorical variable classified into (a) successful: when the infant was able to grasp the object with one or both hands; and (b) unsuccessful: when the infant touched the object, but did not grasp it
|
Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
|
Muscle coactivation
Lasso di tempo: Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
Coactivation between the biceps and triceps muscle during the reaching behavior, measured in percentage (activation of the biceps/activation of the triceps)
|
Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
|
Transport Unit
Lasso di tempo: Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
The relative duration of the first movement unit in relation to total duration of reaching
|
Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
|
Deceleration time
Lasso di tempo: Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
The time necessary for the infant to decelerate the arm movement so that the hand touches an object.
This period of the duration is measured from the time of appearance of the peak of velocity to the end of the reach.
|
Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Investigatori
- Direttore dello studio: Rodrigo Carregaro, PhD, University of Brasilia
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Effettivo)
12 gennaio 2018
Completamento primario (Effettivo)
15 settembre 2018
Completamento dello studio (Effettivo)
15 settembre 2018
Date di iscrizione allo studio
Primo inviato
12 gennaio 2018
Primo inviato che soddisfa i criteri di controllo qualità
18 gennaio 2018
Primo Inserito (Effettivo)
19 gennaio 2018
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
25 febbraio 2019
Ultimo aggiornamento inviato che soddisfa i criteri QC
21 febbraio 2019
Ultimo verificato
1 febbraio 2019
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- Additional Weight Trial
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
NO
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Basso peso alla nascita
-
FibroGenAstraZeneca; Astellas Pharma IncTerminatoAnemia | MDS primaria (Very Low, Low o Intermediate IPSS-R WithStati Uniti, Australia, Belgio, Germania, Israele, Italia, Corea, Repubblica di, Federazione Russa, Spagna, Regno Unito, Francia, Tacchino, Canada, Danimarca, India, Polonia
-
Merck Sharp & Dohme LLCReclutamentoNeoplasie mammarie | Neoplasie mammarie triplo negativo | Neoplasie mammiche HR Low-positive/HER2 negativeSingapore, Stati Uniti, Canada, Hong Kong, Corea del Sud, Taiwan, Ucraina, Giappone, Guatemala, Israele, Sud Africa, Argentina, Cina, Regno Unito, Brasile, Finlandia, Francia, Portogallo, Spagna, Svezia, Perù, Polonia, Australia, Belg... e altro ancora